多发性内分泌腺瘤病1型(MEN1):最佳实践建议与指南
多发性内分泌腺瘤病1型以甲状旁腺肿瘤、十二指肠胰腺神经内分泌肿瘤及垂体前叶腺瘤合并出现为特征,为MEN1基因突变所致的常染色体显性遗传病。为提供最佳评估与管理建议,多学科专家组通过系统综述、Meta分析及Delphi法制定共识,形成55条临床推荐,适用于成人与儿童MEN1的临床实践。
要点
- MEN1由MEN1基因突变引起,表现为甲状旁腺、十二指肠胰腺神经内分泌肿瘤及垂体前叶腺瘤组合发生。
- 早期肿瘤检出和干预可降低MEN1患者的高致残率与早死风险。
- 共识通过系统综述、Meta分析和Delphi法制定,共形成55条临床推荐。
核心结论
- 多学科专家组通过系统综述、Meta分析和Delphi法制定共识,形成55条临床推荐,用于指导成人与儿童MEN1的评估与管理。
研究设计与样本
- 由多学科专家组 convened,开展系统综述与文献Meta分析,并采用Delphi法制定共识声明。
主要发现
- MEN1以甲状旁腺肿瘤、十二指肠胰腺神经内分泌肿瘤及垂体前叶腺瘤合并发生为特征。
- 部分患者还可发生胸腺与支气管肺神经内分泌肿瘤以及肾上腺肿瘤。
- MEN1为MEN1抑癌基因突变导致的常染色体显性遗传病,该基因编码支架蛋白menin。
- 未经治疗的患者致残率高且过早死亡,早期肿瘤检出和干预可减轻上述风险。
- 通过对患者及其一级亲属进行基因检测,可识别MEN1高危个体;对患者及MEN1突变携带者进行定期临床、生化与影像学筛查。
关键数值与推荐
- 共制定55条临床推荐,用于指导成人与儿童MEN1的评估与管理。
临床怎么用
- 原文未据此给出具体临床推荐内容。
局限性
- 原文指出,关于MEN1的最佳评估与管理尚无共识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple endocrine neoplasia type 1 (MEN1) is characterised by combined occurrence of parathyroid tumours, duodenopancreatic neuroendocrine tumours, and anterior pituitary adenomas. Some patients might also develop thymic and bronchopulmonary neuroendocrine tumours, and adrenal tumours. MEN1 is an autosomal dominant disorder caused by mutations in the tumour-suppressor gene MEN1, which encodes a scaffold protein, menin. Without treatment, patients with MEN1 have high morbidity and premature mortality, which can be mitigated by early tumour detection and intervention. Identification of individuals at high risk for MEN1 can be facilitated by genetic testing of patients and their first-degree relatives, and undertaking periodic clinical, biochemical, and radiological screening in patients and MEN1 mutation carriers. However, no consensus exists regarding the optimal assessment and management of MEN1. To provide such recommendations, a multidisciplinary group was convened to undertake systematic reviews and a meta-analysis of the literature, and to use a Delphi approach for the development of consensus statements. 55 clinical recommendations were developed to guide clinicians, patients, and stakeholders about approaches for MEN1 in adults and children.
引用
- Brandi ML, Pieterman CRC, English KA, et al. Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice. Lancet Diabetes Endocrinol. 2025. PMID: 40523372. doi:10.1016/S2213-8587(25)00119-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。